Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7689922rdf:typepubmed:Citationlld:pubmed
pubmed-article:7689922lifeskim:mentionsumls-concept:C0001175lld:lifeskim
pubmed-article:7689922lifeskim:mentionsumls-concept:C0036220lld:lifeskim
pubmed-article:7689922lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7689922lifeskim:mentionsumls-concept:C0005740lld:lifeskim
pubmed-article:7689922lifeskim:mentionsumls-concept:C0034735lld:lifeskim
pubmed-article:7689922lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:7689922pubmed:issue6lld:pubmed
pubmed-article:7689922pubmed:dateCreated1993-10-1lld:pubmed
pubmed-article:7689922pubmed:abstractTextThe authors report three cases of Raynaud phenomenon that developed during doxorubicin, bleomycin, and vincristine (ABV) therapy for acquired immune deficiency syndrome (AIDS)-related Kaposi sarcoma. Although Raynaud phenomenon is well documented as a side effect of bleomycin, vinblastine, and cisplatin chemotherapy for germ cell neoplasms, it has not been widely documented in patients with AIDS.lld:pubmed
pubmed-article:7689922pubmed:languageenglld:pubmed
pubmed-article:7689922pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689922pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7689922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689922pubmed:statusMEDLINElld:pubmed
pubmed-article:7689922pubmed:monthSeplld:pubmed
pubmed-article:7689922pubmed:issn0008-543Xlld:pubmed
pubmed-article:7689922pubmed:authorpubmed-author:Von RoennJ...lld:pubmed
pubmed-article:7689922pubmed:authorpubmed-author:von GuntenC...lld:pubmed
pubmed-article:7689922pubmed:authorpubmed-author:RothE LELlld:pubmed
pubmed-article:7689922pubmed:issnTypePrintlld:pubmed
pubmed-article:7689922pubmed:day15lld:pubmed
pubmed-article:7689922pubmed:volume72lld:pubmed
pubmed-article:7689922pubmed:ownerNLMlld:pubmed
pubmed-article:7689922pubmed:authorsCompleteYlld:pubmed
pubmed-article:7689922pubmed:pagination2004-6lld:pubmed
pubmed-article:7689922pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:meshHeadingpubmed-meshheading:7689922-...lld:pubmed
pubmed-article:7689922pubmed:year1993lld:pubmed
pubmed-article:7689922pubmed:articleTitleRaynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin.lld:pubmed
pubmed-article:7689922pubmed:affiliationNorthwestern University, Chicago, Illinois 60611.lld:pubmed
pubmed-article:7689922pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7689922pubmed:publicationTypeCase Reportslld:pubmed